AGM/EGMJun 22, 2026, 04:08 PM
STAAR Surgical Shareholders Approve 3.9M Share Equity Plan Increase
AI Summary
STAAR Surgical Company held its 2026 Annual Meeting of Shareholders where several key proposals were approved. Shareholders voted to approve Amendment No. 2 to the Amended and Restated Omnibus Equity Incentive Plan, increasing the number of shares reserved for issuance by 3,900,000. Additionally, seven directors were elected, BDO USA, P.C. was ratified as the independent registered public accounting firm, and the compensation of named executive officers was approved on an advisory basis.
Key Highlights
- Shareholders approved Amendment No. 2 to the Omnibus Equity Incentive Plan.
- The plan increases shares reserved for issuance by 3,900,000 shares.
- Seven directors were elected to serve until the 2027 Annual Meeting.
- BDO USA, P.C. was ratified as the independent auditor for fiscal year 2027.
- Executive officer compensation was approved on a non-binding advisory basis.
- A quorum of 43,680,435 shares was represented at the meeting.
Price Impact
More from STAA